Literature DB >> 28034950

Statins for primary prevention in people with a 10% 10-year cardiovascular risk: too much medicine too soon?

Dharani Yerrakalva1, Simon J Griffin1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28034950      PMCID： PMC5198615          DOI： 10.3399/bjgp17X688789

Source DB:  PubMed          Journal:  Br J Gen Pract        ISSN： 0960-1643            Impact factor:   5.386


× No keyword cloud information.
  11 in total

Review 1.  Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis.

Authors:  M R Law; N J Wald; A R Rudnicka
Journal:  BMJ       Date:  2003-06-28

2.  Helping patients decide: ten steps to better risk communication.

Authors:  Angela Fagerlin; Brian J Zikmund-Fisher; Peter A Ubel
Journal:  J Natl Cancer Inst       Date:  2011-09-19       Impact factor: 13.506

3.  Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials.

Authors:  Naveed Sattar; David Preiss; Heather M Murray; Paul Welsh; Brendan M Buckley; Anton J M de Craen; Sreenivasa Rao Kondapally Seshasai; John J McMurray; Dilys J Freeman; J Wouter Jukema; Peter W Macfarlane; Chris J Packard; David J Stott; Rudi G Westendorp; James Shepherd; Barry R Davis; Sara L Pressel; Roberto Marchioli; Rosa Maria Marfisi; Aldo P Maggioni; Luigi Tavazzi; Gianni Tognoni; John Kjekshus; Terje R Pedersen; Thomas J Cook; Antonio M Gotto; Michael B Clearfield; John R Downs; Haruo Nakamura; Yasuo Ohashi; Kyoichi Mizuno; Kausik K Ray; Ian Ford
Journal:  Lancet       Date:  2010-02-16       Impact factor: 79.321

Review 4.  Statins for the primary prevention of cardiovascular disease.

Authors:  Fiona Taylor; Mark D Huffman; Ana Filipa Macedo; Theresa H M Moore; Margaret Burke; George Davey Smith; Kirsten Ward; Shah Ebrahim
Journal:  Cochrane Database Syst Rev       Date:  2013-01-31

Review 5.  Exercise-induced myalgia may limit the cardiovascular benefits of statins.

Authors:  Lionel H Opie
Journal:  Cardiovasc Drugs Ther       Date:  2013-12       Impact factor: 3.727

Review 6.  Statin tolerability: In defence of placebo-controlled trials.

Authors:  Jonathan A Tobert; Connie B Newman
Journal:  Eur J Prev Cardiol       Date:  2015-08-28       Impact factor: 7.804

7.  Impact of statin related media coverage on use of statins: interrupted time series analysis with UK primary care data.

Authors:  Anthony Matthews; Emily Herrett; Antonio Gasparrini; Tjeerd Van Staa; Ben Goldacre; Liam Smeeth; Krishnan Bhaskaran
Journal:  BMJ       Date:  2016-06-28

Review 8.  What proportion of symptomatic side effects in patients taking statins are genuinely caused by the drug? Systematic review of randomized placebo-controlled trials to aid individual patient choice.

Authors:  Judith A Finegold; Charlotte H Manisty; Ben Goldacre; Anthony J Barron; Darrel P Francis
Journal:  Eur J Prev Cardiol       Date:  2014-03-12       Impact factor: 7.804

9.  The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials.

Authors:  B Mihaylova; J Emberson; L Blackwell; A Keech; J Simes; E H Barnes; M Voysey; A Gray; R Collins; C Baigent
Journal:  Lancet       Date:  2012-05-17       Impact factor: 79.321

10.  Estimated 10-year cardiovascular mortality seriously underestimates overall cardiovascular risk.

Authors:  Harald T Jørstad; Ersen B Colkesen; S Matthijs Boekholdt; Jan G Tijssen; Nicholas J Wareham; Kay-Tee Khaw; Ron J Peters
Journal:  Heart       Date:  2015-08-10       Impact factor: 5.994
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.